Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruud H Brakenhoff

Showing results (181-190 of 192) with videos related to

Pageof 20
Sort By:
The Journal of Clinical Investigation|September 25, 2025
Personalized treatment in HPV+ oropharynx cancer using genomic adjusted radiation doseEmily Ho, Loris De Cecco, Steven A Eschrich, et al.
Head & Neck|October 27, 2020
Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU ProjectStefano Cavalieri, Loris De Cecco, Ruud H Brakenhoff, et al.
Journal for Immunotherapy of Cancer|July 22, 2024
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancerNiels E Wondergem, Iris H C Miedema, Rieneke van de Ven, et al.
The Lancet. Oncology|February 16, 2023
Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysisHisham Mehanna, Miren Taberna, Christian von Buchwald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinomaSander R van Hooff, Frank K J Leusink, Paul Roepman, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinomaChristian von Buchwald, Kathrine Kronberg Jakobsen, Amanda-Louise Fenger Carlander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2026
Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck CancerSri Vemulamanda, Aditi Kothari, Loris De Cecco, et al.
Scientific Reports|March 13, 2020
Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancerMarta Bogowicz, Arthur Jochems, Timo M Deist, et al.
Ebiomedicine|November 28, 2022
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensificationPeter Y F Zeng, Matthew J Cecchini, John W Barrett, et al.
Cancer Cell|May 30, 2025
The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targetsJaco C Knol, Mengge Lyu, Franziska Böttger, et al.
Pageof 20

Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
The Journal of Clinical Investigation|September 25, 2025
Personalized treatment in HPV+ oropharynx cancer using genomic adjusted radiation doseEmily Ho, Loris De Cecco, Steven A Eschrich, et al.
Head & Neck|October 27, 2020
Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU ProjectStefano Cavalieri, Loris De Cecco, Ruud H Brakenhoff, et al.
Journal for Immunotherapy of Cancer|July 22, 2024
Circulating T cell status and molecular imaging may predict clinical benefit of neoadjuvant PD-1 blockade in oral cancerNiels E Wondergem, Iris H C Miedema, Rieneke van de Ven, et al.
The Lancet. Oncology|February 16, 2023
Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysisHisham Mehanna, Miren Taberna, Christian von Buchwald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 10, 2012
Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinomaSander R van Hooff, Frank K J Leusink, Paul Roepman, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2024
TNM 8 staging system beyond p16: Double HPV/p16 status is superior to p16 alone in predicting outcome in oropharyngeal squamous cell carcinomaChristian von Buchwald, Kathrine Kronberg Jakobsen, Amanda-Louise Fenger Carlander, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2026
Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck CancerSri Vemulamanda, Aditi Kothari, Loris De Cecco, et al.
Scientific Reports|March 13, 2020
Privacy-preserving distributed learning of radiomics to predict overall survival and HPV status in head and neck cancerMarta Bogowicz, Arthur Jochems, Timo M Deist, et al.
Ebiomedicine|November 28, 2022
Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensificationPeter Y F Zeng, Matthew J Cecchini, John W Barrett, et al.
Cancer Cell|May 30, 2025
The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targetsJaco C Knol, Mengge Lyu, Franziska Böttger, et al.
Pageof 20